- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 17.05M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 16.69M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 16.27M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $46.77M |
| Capex | Q1 2026 · Mar 31, 2025 | $38.87M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$45.78M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$30.06M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $4.62B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $14.69M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $14.69M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $21.33M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $16.81M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $23.13M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$241.14M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$173.9M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $189.56M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $261.36M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.07B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.06B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $242.27M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $224.37M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.84B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.89B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$4.41 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$4.38 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$4.41 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$4.38 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $57.83M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $46.97M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$73.56M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$71.32M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $6.64M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $9.74M |
| Revenue | Q1 2026 · Mar 31, 2026 | $244.68M |
| Revenue | Q1 2026 · Mar 31, 2025 | $231.33M |